Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$3.64 -0.02 (-0.55%)
At close: Oct 21, 2026 · 4:00 PM EDT

Recursion Pharmaceuticals (RXRX) Long-Term Debt Repayments (2020 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) reported Long-Term Debt Repayments of $2.25 million for Q2 2026, up 8.0% from $2.08 million a year earlier and up 1.9% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Long-Term Debt Repayments (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Recursion Pharmaceuticals' Long-Term Debt Repayments came in at $8.75 million, up 2.7% year-over-year; for FY2025, it was $8.43 million, up 89.8% from FY2024.

  • Long-Term Debt Repayments has increased for three consecutive years, with a five-year compound annual growth rate of 155.8% (FY2020 to FY2025).
  • By year, Long-Term Debt Repayments came in at $4.44 million in FY2024 (+479.6%), $766,000 in FY2023 (+751.1%), $90,000 in FY2022 (-99.3%) and $12.8 million in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Long-Term Debt Repayments since Q3 2024.
  • Year over year, Long-Term Debt Repayments has now increased in each of the last three quarters, with growth averaging 43.0% over the last five quarters.
  • The high point for year-over-year Long-Term Debt Repayments in five years was Q4 2024 (growth of 202.7%); the low point was Q3 2022 (a decline of 99.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.21 million (Q1 2026), $2.17 million (Q4 2025) and $2.13 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Recursion Pharmaceuticals 1.95 Bn -654.48 Mn -3.82 Mn 2.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.25 Mn
Mar 31, 2026 2.21 Mn
Dec 31, 2025 2.17 Mn
Sep 30, 2025 2.13 Mn
Jun 30, 2025 2.08 Mn
Mar 31, 2025 2.05 Mn
Dec 31, 2024 2.10 Mn
Sep 30, 2024 2.29 Mn
Jun 30, 2024 26,000.00
Mar 31, 2024 26,000.00
Dec 31, 2023 694,000.00
Sep 30, 2023 24,000.00
Jun 30, 2023 24,000.00
Mar 31, 2023 24,000.00
Dec 31, 2022 23,000.00
Sep 30, 2022 23,000.00
Jun 30, 2022 22,000.00
Mar 31, 2022 22,000.00
Dec 31, 2021 21,000.00
Sep 30, 2021 12.74 Mn
API Access

Recursion Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=RXRX&period=max&api_key=YOUR_API_KEY